Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study.
Kaili Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin Zhao(Shandong University), Yang Ge(Merck & Co., Inc., Rahway, NJ, USA (United States)), Qin Li(Hunan University), Yan Zhang(Qingdao University), Yunbo Zhao(University of Science and Technology of China), Yusheng Wang(Hunan Agricultural University), Chuanhua Zhao(Chinese PLA General Hospital), Jing Zhou(Sichuan Agricultural University), Lu Han(Songjiang District Central Hospital), Shikai Wu(Hebei Medical University)
Cited by 1
Related Papers
Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion
|Cell Research|2013|395
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
|Cephalalgia|2011|263
The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients
|Biological Trace Element Research|1997|122
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
|Cell Death and Disease|2022|110
A Novel Analgesic Isolated from a Traditional Chinese Medicine
|Current Biology|2014|98